{"id":"https://openalex.org/W188703145","doi":"https://doi.org/10.2165/11592810-000000000-00000","title":"Glucagon-like Peptide\u20131 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents","display_name":"Glucagon-like Peptide\u20131 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents","alternate_titles":[],"publication_year":2011,"publication_date":"2011-09-01","ids":{"openalex":"https://openalex.org/W188703145","doi":"https://doi.org/10.2165/11592810-000000000-00000","mag":"188703145","pmid":"https://pubmed.ncbi.nlm.nih.gov/21902291"},"language":"en","primary_location":{"id":"doi:10.2165/11592810-000000000-00000","doi":"https://doi.org/10.2165/11592810-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11592810-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W188703145"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105783630","display_name":"Baptist Gallwitz","orcid":"https://orcid.org/0000-0002-8880-6409","observed_orcids":["https://orcid.org/0000-0002-8880-6409"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Baptist Gallwitz","raw_affiliation_strings":["Medizinische Klinik IV, Eberhard-Karls University, T\u00fcbingen, Germany. baptist.gallwitz@med.uni-tuebingen.de","Medizinische Klinik IV, Eberhard-Karls University, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik IV, Eberhard-Karls University, T\u00fcbingen, Germany. baptist.gallwitz@med.uni-tuebingen.de","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Medizinische Klinik IV, Eberhard-Karls University, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105783630"],"corresponding_institution_ids":["https://openalex.org/I8087733"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":null,"fwci":2.0355,"has_fulltext":false,"cited_by_count":152,"citation_normalized_percentile":{"value":0.89666037,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"71","issue":"13","first_page":"1675","last_page":"1688"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8899999856948853},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9739999771118164},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9610000252723694},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/exenatide-once-weekly","display_name":"exenatide once weekly","score":0.9419999718666077},{"id":"https://openalex.org/keywords/long-acting-glp-1-receptor-agonists","display_name":"long-acting GLP-1 receptor agonists","score":0.9490000009536743},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.8299999833106995},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.8019999861717224},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6980000138282776},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6859999895095825},{"id":"https://openalex.org/keywords/treatment-algorithm","display_name":"treatment algorithm","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9478968381881714},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9392326474189758},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8449718952178955},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.8136085271835327},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.7035524249076843},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5947130918502808},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5868368744850159},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.526191771030426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4745510518550873},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47289812564849854},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4673585891723633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4622129797935486},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.4332357347011566},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.420841783285141}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/11592810-000000000-00000","doi":"https://doi.org/10.2165/11592810-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11592810-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmid:21902291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21902291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":98,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W207706927","https://openalex.org/W219049085","https://openalex.org/W1507814807","https://openalex.org/W1547073044","https://openalex.org/W1558182564","https://openalex.org/W1571606858","https://openalex.org/W1590228841","https://openalex.org/W1598254642","https://openalex.org/W1945989183","https://openalex.org/W1965873026","https://openalex.org/W1968315455","https://openalex.org/W1969932276","https://openalex.org/W1970402700","https://openalex.org/W1970638723","https://openalex.org/W1972602694","https://openalex.org/W1976503602","https://openalex.org/W1977102586","https://openalex.org/W1977574777","https://openalex.org/W1979041860","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1988031087","https://openalex.org/W1994636940","https://openalex.org/W2005230361","https://openalex.org/W2013082477","https://openalex.org/W2013851956","https://openalex.org/W2014732107","https://openalex.org/W2015416604","https://openalex.org/W2016193795","https://openalex.org/W2017444789","https://openalex.org/W2021010531","https://openalex.org/W2021726283","https://openalex.org/W2028272916","https://openalex.org/W2035105326","https://openalex.org/W2039296612","https://openalex.org/W2048811039","https://openalex.org/W2050826565","https://openalex.org/W2054564814","https://openalex.org/W2055849242","https://openalex.org/W2056391616","https://openalex.org/W2061244748","https://openalex.org/W2061862376","https://openalex.org/W2064413574","https://openalex.org/W2065319712","https://openalex.org/W2068488844","https://openalex.org/W2070710390","https://openalex.org/W2071835038","https://openalex.org/W2073547913","https://openalex.org/W2075404533","https://openalex.org/W2076140273","https://openalex.org/W2079667840","https://openalex.org/W2081392051","https://openalex.org/W2082201574","https://openalex.org/W2084948079","https://openalex.org/W2087707716","https://openalex.org/W2094497224","https://openalex.org/W2097085706","https://openalex.org/W2098459806","https://openalex.org/W2107949845","https://openalex.org/W2112694389","https://openalex.org/W2113367996","https://openalex.org/W2113544353","https://openalex.org/W2118762421","https://openalex.org/W2118805427","https://openalex.org/W2119222204","https://openalex.org/W2124122508","https://openalex.org/W2129377335","https://openalex.org/W2129934471","https://openalex.org/W2138077952","https://openalex.org/W2138290933","https://openalex.org/W2139485303","https://openalex.org/W2139634859","https://openalex.org/W2145924144","https://openalex.org/W2146333376","https://openalex.org/W2146901298","https://openalex.org/W2148798434","https://openalex.org/W2152006965","https://openalex.org/W2152569314","https://openalex.org/W2154595662","https://openalex.org/W2155633307","https://openalex.org/W2159205789","https://openalex.org/W2160001758","https://openalex.org/W2160286139","https://openalex.org/W2162934281","https://openalex.org/W2163229244","https://openalex.org/W2164416879","https://openalex.org/W2164518074","https://openalex.org/W2167934167","https://openalex.org/W2170271198","https://openalex.org/W2170606300","https://openalex.org/W2171294019","https://openalex.org/W2344620176","https://openalex.org/W2410165338","https://openalex.org/W2411164089","https://openalex.org/W2509949587","https://openalex.org/W4245477811","https://openalex.org/W4250485558"],"related_works":["https://openalex.org/W1538998865","https://openalex.org/W2016896327","https://openalex.org/W2109093140","https://openalex.org/W2049798496","https://openalex.org/W1220137049","https://openalex.org/W2604623769","https://openalex.org/W2021718572","https://openalex.org/W2277023506","https://openalex.org/W2592545469","https://openalex.org/W3093042356"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W188703145","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":22}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
